第一次体外和体内实验,使用超高剂量氧离子辐射疗法
Celine Karle1,2, Domenico I Filosa1,3, Mahdi Akbarpour1,4,5,6,7
1Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, Heidelberg, Germany.
Physics and imaging in radiation oncology
|July 23, 2025
概括
超高剂量率 (UHDR) 氧离子辐射是可行的和有效的. 在杀死癌细胞和延迟瘤生长方面,UHDR的疗效与标准剂量率相当.
科学领域:
- 辐射瘤学 辐射瘤学
- 生物物理学的生物物理.
- 癌症研究 癌症研究
背景情况:
- 超高剂量率 (UHDR) 辐射是放射瘤学的新兴技术.
- 了解UHDR的生物效应,特别是对于像氧离子这样的高线性能量转移 (LET) 粒子,至关重要.
- 之前的研究已经探讨了UHDR,但其与不同生物复杂性的氧离子的有效性需要进一步调查.
研究的目的:
- 评估超高剂量率 (UHDR) 氧离子辐射的可行性.
- 为了比较UHDR和标准剂量速率 (SDR) 辐射的生物效应.
- 在胰腺癌模型中评估UHDR氧离子辐射的疗效.
主要方法:
- 在生物复杂性的三个层次上研究了UHDR氧离子辐射.
- 在UHDR和SDR下的蛋白质丰富盐溶液中测量氧气消耗.
- 在UHDR和SDR条件下评估胰腺癌细胞杀死 in vitro和瘤生长延迟 in vivo.
主要成果:
- 在富含蛋白质的盐溶液中,UHDR和SDR之间的氧气消耗差异可以忽略不计.
- 在实验室中,UHDR辐射在杀死胰腺癌细胞方面表现出与SDR相似的疗效.
- 与SDR相比,UHDR辐射在体内诱导了类似的瘤生长延迟.
结论:
- UHDR氧离子辐射在不同的生物复杂性中是可行的.
- 用氧离子对UHDR辐射的疗效与SDR对杀死癌细胞和延缓瘤生长的疗效相当.
- 高LET UHDR辐射需要进一步研究在瘤学中的潜在临床应用.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.3K
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
959
相关概念视频
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...